Skip to main content

and
  1. No Access

    Article

    Risk/benefit profile of panitumumab-based therapy in patients with metastatic colorectal cancer: evidence from five randomized controlled trials

    This study aims to evaluate the risk and benefit profiles of panitumumab-based therapy (PBT) in patients with metastatic colorectal cancer (mCRC). Relevant randomized controlled trials were identified by searc...

    Na-** Tang, Hua Li, Yun-Liang Qiu, Guo-Min Zhou, Yan Wang, **g Ma in Tumor Biology (2014)